CIBC Private Wealth Group
COLL icon

CIBC Private Wealth Group’s Collegium Pharmaceutical COLL Stock Holding History

CIBC Private Wealth Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$7.22K Sell
156
-93
-37% -$3.89K ﹤0.01% 2528
2025
Q3 		$8.71K Sell
249
-46
-16% -$1.6K ﹤0.01% 2429
2025
Q2 		$8.72K Buy
295
+46
+18% +$1.31K ﹤0.01% 2299
2025
Q1 		$6.33K Hold
249
– – ﹤0.01% 2391
2024
Q4 		$8.3K Hold
249
– – ﹤0.01% 2326
2024
Q3 		$9.62K Hold
249
– – ﹤0.01% 2416
2024
Q2 		$7.94K Hold
249
– – ﹤0.01% 2370
2024
Q1 		$9.68K Buy
+249
New +$8.71K ﹤0.01% 2290

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIBC Private Wealth Group's COLL Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Collegium Pharmaceutical (COLL) stake by 37% in Q4 2025, selling an estimated $3.89K and leaving 156 shares worth $7.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2528.

CIBC Private Wealth Group first reported a position in COLL in Q1 2024 and has held it in 8 quarters since. The position peaked at $9.68K in Q1 2024. 278 funds tracked by Wall St. Rank hold COLL as of Q4 2025.

  • CIBC Private Wealth Group held 156 shares of Collegium Pharmaceutical worth $7.22K as of Q4 2025.
  • CIBC Private Wealth Group sold 93 Collegium Pharmaceutical shares in Q4 2025, an estimated $3.89K.
  • Collegium Pharmaceutical made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2528 holding.
  • CIBC Private Wealth Group first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Collegium Pharmaceutical position peaked at $9.68K in Q1 2024.
  • 278 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.